Impact of BMI on clinical outcomes of NOAC therapy in daily care - Results of the prospective Dresden NOAC Registry (NCT01588119)

Tittl, L; Endig, S; Marten, S; Reitter, A; Beyer-Westendorf, I; Beyer-Westendorf, J

Beyer-Westendorf, J (reprint author), Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Thrombosis Res Dept Med 1, Div Hematol, Fetscherstr 74, D-01307 Dresden, Germany.

INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018; 262 (): 85

Abstract

Direct acting non-Vitamin K antagonist oral anticoagulants (NOAC) are characterized by a fixed dosing regimen. Despite the potential for relative unde......

Full Text Link